Lv61
2425 积分 2020-05-21 加入
Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein–Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery
3天前
已完结
Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues
4天前
已完结
Discovery of Highly Potent G Protein-Biased Bisamide Kappa Opioid Receptor Agonists
11天前
已完结
Harmonizing the adhesion–release dilemma: a bio-based injectable hypertonic hydrogel for bladder perfusion therapy
12天前
已完结
A simple protocol for Cu-catalyzed protodecarboxylation of (hetero)aromatic carboxylic acids
14天前
已完结
Discovery of BBI-355, a Potent, Selective, and Orally Available Checkpoint Kinase 1 Inhibitor for the Treatment of Extrachromosomal DNA Oncogene-Amplified Cancers
1个月前
已完结
Retrospective Analysis of the Impact of the “Escape from Flatland” Publication on the Merck & Co., Inc., Small Molecule Portfolio
1个月前
已完结
Renal function curve--a key to understanding the pathogenesis of hypertension
1个月前
已完结
Selective cytotoxicity of gemcitabine in bladder cancer cell lines
1个月前
已完结
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα
1个月前
已完结
Interdisciplinary Integration of Computational Thinking in K-12 Education: A Systematic Review
8个月前
已采纳
Millettia speciosa Champ. Leguminosae ameliorates testicular damage in mice by repairing of blood-testis barrier dysfunction and testosterone synthesis
9个月前
已采纳
Outcome and complications of endovascular embolization for vein of Galen malformations: a systematic review and meta-analysis
9个月前
已采纳
一例喉癌根治性切除术的围手术期护理
9个月前
已撤回
共聚焦显微镜的自校正、长时程与高分辨成像方法研究
9个月前
已采纳
Sex Differences in the Pharmacokinetics of Low-dose Ketamine in Plasma and Brain of Male and Female Rats
9个月前
已采纳
A Distribution Study with 14C-Otilonium Bromide in The Rat: Evidence for Selective Tropism for Large Intestine after Oral Administration
9个月前
已采纳
HOW I DO IT: WHOLE LUNG LAVAGE IN PULMONARY ALVEOLAR PROTEINOSIS
9个月前
已采纳
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
9个月前
已采纳
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
9个月前
已采纳
皖公网安备34019202002308
